Sign in
4

Changes in Ownership

Elanco Animal Health Inc Filed Acc 0001415889-22-010280

Options or other derivatives

  • Director acquired 738.65 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kurzius Lawrence Erik Director 2022-09-30 Grant or award · Deferred Stock Units +738.65 $12.41 $9,167 13,057.21 D: show line 1 in the form
Loading xslF345X03/form4-10042022_021057.xml…